Literature DB >> 25029391

Long-term prognosis of hearing loss in patients with unilateral Ménière's disease.

Go Sato1, Kazunori Sekine, Kazunori Matsuda, Hitomi Ueeda, Arata Horii, Suetaka Nishiike, Tadashi Kitahara, Atsushi Uno, Takao Imai, Hidenori Inohara, Noriaki Takeda.   

Abstract

CONCLUSION: The finding of deteriorated hearing loss at the initial visit at middle to high frequencies is a factor of poor hearing prognosis in Ménière's disease. Early intervention with instructions for lifestyle changes may lead to good outcomes in hearing.
OBJECTIVE: An attempt was made to examine long-term changes in hearing loss in unilateral Ménière's disease and factors associated with prognosis of hearing loss retrospectively.
METHODS: Based on their last hearing level of the affected ear, 36 patients were subdivided into two groups: the poor prognosis of hearing (PPH) group and the good prognosis of hearing (GPH) group.
RESULTS: In the PPH group, the hearing levels at the initial visit at middle and high frequencies were significantly worse than those in the GPH group. Moreover, the hearing loss progressed during the first 2 years of the disease, and stayed flat to approximately 50 dB at the later stage. Conversely, the hearing loss at the onset in the GPH group showed no further progression over the first 2 years, and remained constant to approximately 35 dB at the later stage. In addition, the mean intervals from the onset to the initial visit in the PPH group were significantly longer than those in the GPH group.

Entities:  

Keywords:  Endolymphatic hydrops; early intervention; vertigo attack

Mesh:

Year:  2014        PMID: 25029391     DOI: 10.3109/00016489.2014.923114

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

Review 1.  Validity and Reliability of the Diagnostic Tests for Ménière's Disease.

Authors:  Enis Alpin Güneri; Aslı Çakır; Başak Mutlu
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-08-15

2.  Speech Recognition During Follow-Up of Patients with Ménière's Disease: What Are We Missing?

Authors:  Octavio Garaycochea; Raquel Manrique-Huarte; Diego Calavia; Laura Girón; Nicolás Pérez-Fernández
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

3.  Hearing function after betahistine therapy in patients with Ménière's disease.

Authors:  Seyed Javad Seyed Tootoonchi; Samad Ghiasi; Parvaneh Shadara; Simin Mirakhor Samani; Daniel Fadaei Fouladi
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.